Showing 4021-4030 of 21451 results for "".
- Emerging Insights and Innovations in Metabolic Liver Disease Researchhttps://reachmd.com/news/emerging-insights-and-innovations-in-metabolic-liver-disease-research/2485324/A recent study reported a preclinical candidate that produced measurable regression of established liver fibrosis in validated models, a finding directly relevant to m
- Emerging Innovations in Men's Contraceptive Technologyhttps://reachmd.com/news/innovations-mens-contraceptive-technology/2485313/YCT-529 is a non-hormonal male contraceptive in early clinical development, offering a potential new pathway for male contraception. Looking ahead, the drug’s action on spermatogene
- Viral Protein Functions and Host Interactions for Antiviral Drug Designhttps://reachmd.com/news/viral-protein-functions-host-interactions-drug-design/2485304/A new study found that SARS-CoV-2 nucleocapsid phosphorylation acts as a phosphorylation-dependent molecular switch, shifting the nucleocapsid from a genome‑packaging configuration into a dynamic
- Durvalumab in Small Cell Lung Cancer: Insights from the ADRIATIC Trialhttps://reachmd.com/news/durvalumab-sclc-adriatic-trial/2485290/The ADRIATIC trial shows durvalumab maintenance after definitive chemoradiation significantly extends overall survival in limited‑stage small cell lu
- The Impact of Maternity Service Closures on Health Accesshttps://reachmd.com/news/the-impact-of-maternity-service-closures-on-health-access/2485276/Freestanding birth centers are closing across the U.S., widening gaps in maternity and reproductive health
- Impact of VA/DoD CKD Guideline Updates on Nephrology Practicehttps://reachmd.com/news/impact-of-vadod-ckd-guideline-updates-on-nephrology-practice/2485262/The VA/DoD CKD guideline update consolidates risk stratification and expands pharmacotherapy rec
- Understanding Global Eligibility for GLP-1 Therapies: Implications and Opportunitieshttps://reachmd.com/news/understanding-global-eligibility-for-glp-1-therapies-implications-and-opportunities/2485272/More than a quarter of the world's adults meet common eligibility criteria for GLP‑1 receptor agonist weight‑management therapy, a
- Implementing Effective AI Governance in Radiologyhttps://reachmd.com/news/implementing-effective-ai-governance-in-radiology/2485261/Penn Medicine governance model centralizes departmental AI review in radiology, aligning clinical priorities with enterprise stra
- The Role of Decipher Genomic Classifier in Prostate Cancer: Recent Validations and Clinical Implicationshttps://reachmd.com/news/the-role-of-decipher-genomic-classifier-in-prostate-cancer-recent-validations-and-clinical-implications/2485264/The VANDAAM study provides prospective validation that the Decipher genomic classifier predicts 2‑year biochemical recurrence afte
- Global Eligibility and Policy Implications for GLP-1 Receptor Agonistshttps://reachmd.com/news/global-eligibility-and-policy-implications-for-glp-1-receptor-agonists/2485280/Mass General Brigham analysis finds that more than 27% of adults worldwide me